Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL218291 (BCX-1777, Fodosine, Forodesine, NSC-717904) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as reduction in [3H]ethanolamine incorporation incubated for 18 hrs followed by addition of [3H]ethanolamine and measured after 48 hrs by scintillation counting method | F | 7.2 | pIC50 | 63 | nM | IC50 | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
Purine nucleoside phosphorylase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5648] [UniProtKB: Q8T9Z7] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum His-tagged PNP assessed as inhibitor constant for enzyme-inhibitor complex formation | B | 7.54 | pKi | 29 | nM | Ki | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
ChEMBL | Inhibition of Plasmodium falciparum PNP expressed in Escherichia coli BL21(DE3) cells by spectrophotometry | B | 9.07 | pKi | 0.86 | nM | Ki | Eur J Med Chem (2010) 45: 5140-5149 [PMID:20817362] |
ChEMBL | Inhibition of Plasmodium falciparum His-tagged PNP assessed as inhibitor constant for enzyme-inhibitor-substrate complex formation | B | 9.22 | pKi | 0.6 | nM | Ki | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
purine nucleoside phosphorylase/Purine nucleoside phosphorylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4338] [GtoPdb: 2841] [UniProtKB: P00491] | ||||||||
ChEMBL | Inhibition of human PNP | B | 10.25 | pKd | 0.06 | nM | Kd | Eur J Med Chem (2010) 45: 5140-5149 [PMID:20817362] |
ChEMBL | Inhibition of human PNP assessed as inhibitor constant for enzyme-inhibitor-substrate complex formation | B | 7.14 | pKi | 72 | nM | Ki | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
ChEMBL | Initial binding affinity to human PNP His257Gly mutant | B | 7.96 | pKi | 11 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 5900-5903 [PMID:18778937] |
ChEMBL | Initial binding affinity to wild type human PNP | B | 8.48 | pKi | 3.3 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 5900-5903 [PMID:18778937] |
ChEMBL | Inhibition of human purine nucleoside phosphorylase; Initial rate. | B | 8.48 | pKi | 3.3 | nM | Ki | J Med Chem (2003) 46: 3412-3423 [PMID:12852771] |
ChEMBL | Binding affinity towards Human Purine Nucleoside Phosphorylase was reported | B | 8.48 | pKi | 3.3 | nM | Ki | J Med Chem (2003) 46: 5271-5276 [PMID:14613329] |
ChEMBL | Inhibition of human PNP activity | B | 8.74 | pKi | 1.8 | nM | Ki | J Med Chem (2006) 49: 6037-6045 [PMID:17004717] |
GtoPdb | - | - | 10.14 | pKi | 0.07 | nM | Ki | Biochemistry (1998) 37: 8615-21 [PMID:9628722] |
ChEMBL | Inhibitory activity of compound against human purine nucleoside phosphorylase (PNP) | B | 10.14 | pKi | 0.07 | nM | Ki | J Med Chem (2003) 46: 155-160 [PMID:12502369] |
ChEMBL | Equilibrium binding affinity to wild type human PNP | B | 10.24 | pKi | 0.06 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 5900-5903 [PMID:18778937] |
ChEMBL | Inhibitory activity of compound against human purine nucleoside phosphorylase (PNP) | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2004) 47: 3275-3281 [PMID:15163207] |
ChEMBL | Inhibition of human PNP by xanthine-oxidase coupled assay | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2009) 52: 1126-1143 [PMID:19170524] |
ChEMBL | Dissociation constant against Human Purine Nucleoside Phosphorylase was reported | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2003) 46: 5271-5276 [PMID:14613329] |
ChEMBL | Inhibition of human PNP using inosine as substrate by xanthine oxidase coupled assay | B | 10.25 | pKi | 0.06 | nM | Ki | Medchemcomm (2018) 9: 1983-1993 [PMID:30627387] |
ChEMBL | Equilibrium dissociation constant determined against human purine nucleoside phosphorylase (PNP) after slow-onset inhibition | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2003) 46: 3412-3423 [PMID:12852771] |
ChEMBL | Inhibition of human purine nucleoside phosphorylase | B | 7 | pIC50 | 100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2627-2629 [PMID:19386496] |
ChEMBL | Inhibition of human PNP activity | B | 8.46 | pIC50 | 3.5 | nM | IC50 | J Med Chem (2006) 49: 6037-6045 [PMID:17004717] |
Purine nucleoside phosphorylase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2935] [UniProtKB: P55859] | ||||||||
ChEMBL | Binding affinity to calf recombinant PNP expressed in Escherichia coli BL21 (DE3) by isothermal titration calorimetry | B | 10.64 | pKd | 0.02 | nM | Kd | Bioorg Med Chem (2012) 20: 6758-6769 [PMID:23040896] |
ChEMBL | Inhibition of calf spleen PNP assessed as inhibition of 7-methylguanosine phosphorolysis after 50 mins by spectrophotometry in presence of 50 mM inorganic phosphate | B | 7.39 | pKi | 41 | nM | Ki | Bioorg Med Chem (2010) 18: 2275-2284 [PMID:20189401] |
ChEMBL | Inhibitory activity of compound against bovine purine nucleoside phosphorylase (PNP) | B | 10.64 | pKi | 0.02 | nM | Ki | J Med Chem (2003) 46: 155-160 [PMID:12502369] |
ChEMBL | Inhibition of bovine spleen PNP using inosine as substrate by xanthine oxidase coupled assay | B | 10.64 | pKi | 0.02 | nM | Ki | Medchemcomm (2018) 9: 1983-1993 [PMID:30627387] |
Plasmodium falciparum purine nucleoside phosphorylase in Plasmodium falciparum [GtoPdb: 3077] | ||||||||
GtoPdb | - | - | 9.22 | pKi | 0.6 | nM | Ki | J Biol Chem (2002) 277: 3219-25 [PMID:11707439] |
GtoPdb | Parasite growth inhibition assay | - | 7.46 | pIC50 | 35 | nM | IC50 | J Biol Chem (2002) 277: 3226-31 [PMID:11706018] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]